Click for best price
Microarray Patch Transdermal Drug Delivery Systems Market Size, Share 2024
| Market size in 2023 |
US$ 27.42 billion
|
Forecast Market size by 2029 |
US$ 38.9 billion
|
| Growth Rate |
CAGR of 11.8% |
Number of Pages |
115 Pages |
The global Microarray Patch Transdermal Drug Delivery Systems market was valued at US$ 27.42 billion in 2023 and is projected to reach US$ 38.9 billion by 2029, at a CAGR of 11.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Microarray patch transdermal drug delivery systems consist of tiny protrusions that stick to the body like small bandages that painlessly penetrate the outermost layer of the skin to deliver the drug or vaccine to the top layer of the skin. This drug delivery system is simpler than traditional drug delivery methods and can also reduce a certain risk of infection, ensuring the safety of patients.
This report aims to provide a comprehensive presentation of the global market for Microarray Patch Transdermal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microarray Patch Transdermal Drug Delivery Systems. This report contains market size and forecasts of Microarray Patch Transdermal Drug Delivery Systems in global, including the following market information:
- Global Microarray Patch Transdermal Drug Delivery Systems Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Microarray Patch Transdermal Drug Delivery Systems Market Sales, 2018-2023, 2024-2032, (K Units)
- Global top five Microarray Patch Transdermal Drug Delivery Systems companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Solid Microneedles Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Microarray Patch Transdermal Drug Delivery Systems include 3M, Becton, Endoderma, BD, Zosano Pharma, Raphas, Nanopass Tech, Corium International and Valeritas, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Microarray Patch Transdermal Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microarray Patch Transdermal Drug Delivery Systems Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Microarray Patch Transdermal Drug Delivery Systems Market Segment Percentages, by Type, 2023 (%)
- Solid Microneedles
- Hollow Microneedles
- Dissolving Microneedles
Global Microarray Patch Transdermal Drug Delivery Systems Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Microarray Patch Transdermal Drug Delivery Systems Market Segment Percentages, by Application, 2023 (%)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Global Microarray Patch Transdermal Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Microarray Patch Transdermal Drug Delivery Systems Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Microarray Patch Transdermal Drug Delivery Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Microarray Patch Transdermal Drug Delivery Systems revenues share in global market, 2023 (%)
- Key companies Microarray Patch Transdermal Drug Delivery Systems sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Microarray Patch Transdermal Drug Delivery Systems sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 3M
- Becton
- Endoderma
- BD
- Zosano Pharma
- Raphas
- Nanopass Tech
- Corium International
- Valeritas
- Nitto Denko
- Microdermics
- TheraJect
- Vaxxas
- KINDEVA
- QuadMedicine
- SNvia
- Small Lab
- Lohmann Therapie-Systeme
- AdminMed Nano BioSciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Microarray Patch Transdermal Drug Delivery Systems, market overview.
Chapter 2: Global Microarray Patch Transdermal Drug Delivery Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Microarray Patch Transdermal Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Microarray Patch Transdermal Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Microarray Patch Transdermal Drug Delivery Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Microarray Patch Transdermal Drug Delivery Systems Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 27.42 billion
|
| Forecast Market size by 2029 |
US$ 38.9 billion
|
| Growth Rate |
CAGR of 11.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Microarray Patch Transdermal Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microarray Patch Transdermal Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microarray Patch Transdermal Drug Delivery Systems Overall Market Size
2.1 Global Microarray Patch Transdermal Drug Delivery Systems Market Size: 2022 VS 2032
2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales: 2018-2032
3 Company Landscape
3.1 Top Microarray Patch Transdermal Drug Delivery Systems Players in Global Market
3.2 Top Global Microarray Patch Transdermal Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Companies
3.4 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Companies
3.5 Global Microarray Patch Transdermal Drug Delivery Systems Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Microarray Patch Transdermal Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Microarray Patch Transdermal Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Microarray Patch Transdermal Drug Delivery Systems Players in Global Market
3.8.1 List of Global Tier 1 Microarray Patch Transdermal Drug Delivery Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Microarray Patch Transdermal Drug Delivery Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Market Size Markets, 2022 & 2032
4.1.2 Solid Microneedles
4.1.3 Hollow Microneedles
4.1.4 Dissolving Microneedles
4.2 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, 2024-2032
4.2.3 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
4.3 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Sales & Forecasts
4.3.1 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2023
4.3.2 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Sales, 2024-2032
4.3.3 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
4.4 By Type - Global Microarray Patch Transdermal Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, 2024-2032
5.2.3 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
5.3 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Sales & Forecasts
5.3.1 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2023
5.3.2 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Sales, 2024-2032
5.3.3 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
5.4 By Application - Global Microarray Patch Transdermal Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Market Size, 2022 & 2032
6.2 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, 2024-2032
6.2.3 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
6.3 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Sales & Forecasts
6.3.1 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2023
6.3.2 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Sales, 2024-2032
6.3.3 By Region - Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2032
6.4.2 By Country - North America Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2032
6.4.3 US Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.4.4 Canada Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.4.5 Mexico Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2032
6.5.2 By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2032
6.5.3 Germany Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.5.4 France Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.5.5 U.K. Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.5.6 Italy Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.5.7 Russia Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.5.8 Nordic Countries Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.5.9 Benelux Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2032
6.6.2 By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2032
6.6.3 China Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.6.4 Japan Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.6.5 South Korea Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.6.6 Southeast Asia Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.6.7 India Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2032
6.7.2 By Country - South America Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2032
6.7.3 Brazil Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.7.4 Argentina Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Sales, 2018-2032
6.8.3 Turkey Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.8.4 Israel Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.8.5 Saudi Arabia Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
6.8.6 UAE Microarray Patch Transdermal Drug Delivery Systems Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.1.4 3M Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 Becton
7.2.1 Becton Company Summary
7.2.2 Becton Business Overview
7.2.3 Becton Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.2.4 Becton Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.2.5 Becton Key News & Latest Developments
7.3 Endoderma
7.3.1 Endoderma Company Summary
7.3.2 Endoderma Business Overview
7.3.3 Endoderma Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.3.4 Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.3.5 Endoderma Key News & Latest Developments
7.4 BD
7.4.1 BD Company Summary
7.4.2 BD Business Overview
7.4.3 BD Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.4.4 BD Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.4.5 BD Key News & Latest Developments
7.5 Zosano Pharma
7.5.1 Zosano Pharma Company Summary
7.5.2 Zosano Pharma Business Overview
7.5.3 Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.5.4 Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.5.5 Zosano Pharma Key News & Latest Developments
7.6 Raphas
7.6.1 Raphas Company Summary
7.6.2 Raphas Business Overview
7.6.3 Raphas Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.6.4 Raphas Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.6.5 Raphas Key News & Latest Developments
7.7 Nanopass Tech
7.7.1 Nanopass Tech Company Summary
7.7.2 Nanopass Tech Business Overview
7.7.3 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.7.4 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.7.5 Nanopass Tech Key News & Latest Developments
7.8 Corium International
7.8.1 Corium International Company Summary
7.8.2 Corium International Business Overview
7.8.3 Corium International Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.8.4 Corium International Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.8.5 Corium International Key News & Latest Developments
7.9 Valeritas
7.9.1 Valeritas Company Summary
7.9.2 Valeritas Business Overview
7.9.3 Valeritas Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.9.4 Valeritas Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.9.5 Valeritas Key News & Latest Developments
7.10 Nitto Denko
7.10.1 Nitto Denko Company Summary
7.10.2 Nitto Denko Business Overview
7.10.3 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.10.4 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.10.5 Nitto Denko Key News & Latest Developments
7.11 Microdermics
7.11.1 Microdermics Company Summary
7.11.2 Microdermics Microarray Patch Transdermal Drug Delivery Systems Business Overview
7.11.3 Microdermics Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.11.4 Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.11.5 Microdermics Key News & Latest Developments
7.12 TheraJect
7.12.1 TheraJect Company Summary
7.12.2 TheraJect Microarray Patch Transdermal Drug Delivery Systems Business Overview
7.12.3 TheraJect Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.12.4 TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.12.5 TheraJect Key News & Latest Developments
7.13 Vaxxas
7.13.1 Vaxxas Company Summary
7.13.2 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Business Overview
7.13.3 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.13.4 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.13.5 Vaxxas Key News & Latest Developments
7.14 KINDEVA
7.14.1 KINDEVA Company Summary
7.14.2 KINDEVA Business Overview
7.14.3 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.14.4 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.14.5 KINDEVA Key News & Latest Developments
7.15 QuadMedicine
7.15.1 QuadMedicine Company Summary
7.15.2 QuadMedicine Business Overview
7.15.3 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.15.4 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.15.5 QuadMedicine Key News & Latest Developments
7.16 SNvia
7.16.1 SNvia Company Summary
7.16.2 SNvia Business Overview
7.16.3 SNvia Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.16.4 SNvia Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.16.5 SNvia Key News & Latest Developments
7.17 Small Lab
7.17.1 Small Lab Company Summary
7.17.2 Small Lab Business Overview
7.17.3 Small Lab Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.17.4 Small Lab Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.17.5 Small Lab Key News & Latest Developments
7.18 Lohmann Therapie-Systeme
7.18.1 Lohmann Therapie-Systeme Company Summary
7.18.2 Lohmann Therapie-Systeme Business Overview
7.18.3 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.18.4 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.18.5 Lohmann Therapie-Systeme Key News & Latest Developments
7.19 AdminMed Nano BioSciences
7.19.1 AdminMed Nano BioSciences Company Summary
7.19.2 AdminMed Nano BioSciences Business Overview
7.19.3 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Major Product Offerings
7.19.4 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.19.5 AdminMed Nano BioSciences Key News & Latest Developments
8 Global Microarray Patch Transdermal Drug Delivery Systems Production Capacity, Analysis
8.1 Global Microarray Patch Transdermal Drug Delivery Systems Production Capacity, 2018-2032
8.2 Microarray Patch Transdermal Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Microarray Patch Transdermal Drug Delivery Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Microarray Patch Transdermal Drug Delivery Systems Supply Chain Analysis
10.1 Microarray Patch Transdermal Drug Delivery Systems Industry Value Chain
10.2 Microarray Patch Transdermal Drug Delivery Systems Upstream Market
10.3 Microarray Patch Transdermal Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Microarray Patch Transdermal Drug Delivery Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Microarray Patch Transdermal Drug Delivery Systems in Global Market
Table 2. Top Microarray Patch Transdermal Drug Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Companies, 2018-2023
Table 5. Global Microarray Patch Transdermal Drug Delivery Systems Sales by Companies, (K Units), 2018-2023
Table 6. Global Microarray Patch Transdermal Drug Delivery Systems Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Microarray Patch Transdermal Drug Delivery Systems Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Microarray Patch Transdermal Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Microarray Patch Transdermal Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microarray Patch Transdermal Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), 2018-2023
Table 15. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), 2024-2032
Table 16. By Application ? Global Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), 2018-2023
Table 20. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), 2024-2032
Table 21. By Region ? Global Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), 2018-2023
Table 25. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), 2024-2032
Table 26. By Country - North America Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2018-2023
Table 29. By Country - North America Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2024-2032
Table 30. By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2018-2023
Table 33. By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2024-2032
Table 34. By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2018-2023
Table 37. By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2024-2032
Table 38. By Country - South America Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2018-2023
Table 41. By Country - South America Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Sales, (K Units), 2024-2032
Table 46. 3M Company Summary
Table 47. 3M Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 48. 3M Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. 3M Key News & Latest Developments
Table 50. Becton Company Summary
Table 51. Becton Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 52. Becton Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Becton Key News & Latest Developments
Table 54. Endoderma Company Summary
Table 55. Endoderma Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 56. Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Endoderma Key News & Latest Developments
Table 58. BD Company Summary
Table 59. BD Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 60. BD Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. BD Key News & Latest Developments
Table 62. Zosano Pharma Company Summary
Table 63. Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 64. Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Zosano Pharma Key News & Latest Developments
Table 66. Raphas Company Summary
Table 67. Raphas Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 68. Raphas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Raphas Key News & Latest Developments
Table 70. Nanopass Tech Company Summary
Table 71. Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 72. Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Nanopass Tech Key News & Latest Developments
Table 74. Corium International Company Summary
Table 75. Corium International Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 76. Corium International Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Corium International Key News & Latest Developments
Table 78. Valeritas Company Summary
Table 79. Valeritas Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 80. Valeritas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Valeritas Key News & Latest Developments
Table 82. Nitto Denko Company Summary
Table 83. Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 84. Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Nitto Denko Key News & Latest Developments
Table 86. Microdermics Company Summary
Table 87. Microdermics Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 88. Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Microdermics Key News & Latest Developments
Table 90. TheraJect Company Summary
Table 91. TheraJect Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 92. TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. TheraJect Key News & Latest Developments
Table 94. Vaxxas Company Summary
Table 95. Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 96. Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Vaxxas Key News & Latest Developments
Table 98. KINDEVA Company Summary
Table 99. KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 100. KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. KINDEVA Key News & Latest Developments
Table 102. QuadMedicine Company Summary
Table 103. QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 104. QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. QuadMedicine Key News & Latest Developments
Table 106. SNvia Company Summary
Table 107. SNvia Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 108. SNvia Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. SNvia Key News & Latest Developments
Table 110. Small Lab Company Summary
Table 111. Small Lab Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 112. Small Lab Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Small Lab Key News & Latest Developments
Table 114. Lohmann Therapie-Systeme Company Summary
Table 115. Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 116. Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Lohmann Therapie-Systeme Key News & Latest Developments
Table 118. AdminMed Nano BioSciences Company Summary
Table 119. AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product Offerings
Table 120. AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. AdminMed Nano BioSciences Key News & Latest Developments
Table 122. Microarray Patch Transdermal Drug Delivery Systems Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Microarray Patch Transdermal Drug Delivery Systems Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Microarray Patch Transdermal Drug Delivery Systems Production by Region, 2018-2023 (K Units)
Table 125. Global Microarray Patch Transdermal Drug Delivery Systems Production by Region, 2024-2032 (K Units)
Table 126. Microarray Patch Transdermal Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 127. Microarray Patch Transdermal Drug Delivery Systems Market Drivers in Global Market
Table 128. Microarray Patch Transdermal Drug Delivery Systems Market Restraints in Global Market
Table 129. Microarray Patch Transdermal Drug Delivery Systems Raw Materials
Table 130. Microarray Patch Transdermal Drug Delivery Systems Raw Materials Suppliers in Global Market
Table 131. Typical Microarray Patch Transdermal Drug Delivery Systems Downstream
Table 132. Microarray Patch Transdermal Drug Delivery Systems Downstream Clients in Global Market
Table 133. Microarray Patch Transdermal Drug Delivery Systems Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Microarray Patch Transdermal Drug Delivery Systems Segment by Type in 2022
Figure 2. Microarray Patch Transdermal Drug Delivery Systems Segment by Application in 2022
Figure 3. Global Microarray Patch Transdermal Drug Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Microarray Patch Transdermal Drug Delivery Systems Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Microarray Patch Transdermal Drug Delivery Systems Revenue, 2018-2032 (US$, Mn)
Figure 7. Microarray Patch Transdermal Drug Delivery Systems Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Microarray Patch Transdermal Drug Delivery Systems Revenue in 2022
Figure 9. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 11. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 12. By Type - Global Microarray Patch Transdermal Drug Delivery Systems Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 15. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 16. By Application - Global Microarray Patch Transdermal Drug Delivery Systems Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 20. By Region - Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 21. By Country - North America Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 22. By Country - North America Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 23. US Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 28. Germany Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 29. France Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 37. China Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 41. India Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 43. By Country - South America Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 44. Brazil Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Sales Market Share, 2018-2032
Figure 48. Turkey Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 52. Global Microarray Patch Transdermal Drug Delivery Systems Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Microarray Patch Transdermal Drug Delivery Systems by Region, 2022 VS 2032
Figure 54. Microarray Patch Transdermal Drug Delivery Systems Industry Value Chain
Figure 55. Marketing Channels
